Avient Announces First Quarter 2025 Results

Avient Corporation announced its first quarter results for 2025.  The company reported first quarter sales of $826.6 million compared to $829 million in the prior year quarter. First quarter GAAP earnings per share (EPS) were ($0.22) compared to $0.54 in the prior year quarter. 

First quarter 2025 adjusted EPS was $0.76 compared to $0.76 in the prior year quarter.  This translates to 4% adjusted EPS growth, excluding the unfavorable impact of foreign exchange.

“I’m pleased with our team’s execution this quarter to deliver these results in a volatile and changing macro-economic backdrop,” said Dr. Ashish Khandpur, president and CEO, Avient Corporation.

“The evolving trade policy has led to uncertainty impacting demand in certain markets and geographies, particularly in the U.S.  Despite this, our teams delivered organic sales growth for the fourth consecutive quarter and expanded adjusted EBITDA margins 20 basis points to 17.5%.  These results were achieved by remaining focused on our customers and staying agile to the changing market conditions.  We further streamlined our structure to better serve our customers and markets, controlled our direct and indirect costs, while still prioritizing investments in our growth vectors aligned to our strategy,” added Dr. Khandpur.

“From a regional perspective, Asia and Latin America delivered strong results, growing organic sales 9% and 17%, respectively,” Dr. Khandpur continued.  “EMEA delivered a fourth consecutive quarter of growth, increasing organic sales by 2%. Weaker consumer sentiment led to a 3% decline in the U.S. and Canada.”

2025 Outlook

“Looking ahead to the second quarter, we expect continued volatility in demand as consumers and businesses assess the changing economic landscape,” said Jamie Beggs, SVP and CFO, Avient Corporation.  “While we anticipate weakness in consumer and transportation end markets, we see opportunities for growth in our largest end market, packaging, as well as strength in our high profit portfolios in defense and healthcare.   As such, we expect second quarter adjusted EPS of $0.79, which represents 4% growth over the prior year quarter.”

“The full year outlook is less certain and highly dependent on global economic growth, which is currently hard to predict.  However, our current operational performance is in-line with expectations, and we are keeping our full year guidance range unchanged for adjusted EBITDA of $540 to $570 million and adjusted EPS of $2.70 to $2.94.  Furthermore, given our strong cash position and expectation for free cash flow this year, we intend to pay down between $100 to $200 million of debt by year-end,” said Beggs.

Dr. Khandpur added, “While the level of macro-economic uncertainty has increased, we are well positioned to help our customers across the globe navigate this new environment.  For the most part, we source raw materials and manufacture our products locally in the regions we serve, so we expect minimal direct impact from tariffs announced to date.  We are focused on executing what we can influence, which includes staying close to our customers, winning share and new business, proactively working to offset raw material or tariff-related inflation, controlling our costs and strengthening our balance sheet.”